Standard
Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV-PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1-(13) C]pyruvate. / Asghar Butt, Sadia; Søgaard, Lise V; Ardenkjaer-Larsen, Jan H; Lauritzen, Mette H; Engelholm, Lars H; Paulson, Olaf B.; Mirza, Osman Asghar; Holck, Susanne; Magnusson, Peter; Akeson, Per.
I:
Magnetic Resonance in Medicine, Bind 73, 16.01.2015, s. 51-58.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Asghar Butt, S, Søgaard, LV, Ardenkjaer-Larsen, JH, Lauritzen, MH, Engelholm, LH
, Paulson, OB, Mirza, OA, Holck, S, Magnusson, P & Akeson, P 2015, '
Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV-PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1-(13) C]pyruvate',
Magnetic Resonance in Medicine, bind 73, s. 51-58.
https://doi.org/10.1002/mrm.25095APA
Asghar Butt, S., Søgaard, L. V., Ardenkjaer-Larsen, J. H., Lauritzen, M. H., Engelholm, L. H.
, Paulson, O. B., Mirza, O. A., Holck, S., Magnusson, P., & Akeson, P. (2015).
Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV-PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1-(13) C]pyruvate.
Magnetic Resonance in Medicine,
73, 51-58.
https://doi.org/10.1002/mrm.25095Vancouver
Asghar Butt S, Søgaard LV, Ardenkjaer-Larsen JH, Lauritzen MH, Engelholm LH
, Paulson OB o.a.
Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV-PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1-(13) C]pyruvate.
Magnetic Resonance in Medicine. 2015 jan. 16;73:51-58.
https://doi.org/10.1002/mrm.25095Author
Asghar Butt, Sadia ; Søgaard, Lise V ; Ardenkjaer-Larsen, Jan H ; Lauritzen, Mette H ; Engelholm, Lars H ; Paulson, Olaf B. ; Mirza, Osman Asghar ; Holck, Susanne ; Magnusson, Peter ; Akeson, Per. / Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV-PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1-(13) C]pyruvate. I: Magnetic Resonance in Medicine. 2015 ; Bind 73. s. 51-58.
Bibtex
@article{55870b03a65b4797ba0ae08b482f9c11,
title = "Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV-PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1-(13) C]pyruvate",
abstract = "To use dynamic magnetic resonance spectroscopy (MRS) of hyperpolarized (13) C-pyruvate to follow the progress over time in vivo of breast cancer metabolism in the MMTV-PymT model, and to follow the response to the anti-estrogen drug tamoxifen.",
author = "{Asghar Butt}, Sadia and S{\o}gaard, {Lise V} and Ardenkjaer-Larsen, {Jan H} and Lauritzen, {Mette H} and Engelholm, {Lars H} and Paulson, {Olaf B.} and Mirza, {Osman Asghar} and Susanne Holck and Peter Magnusson and Per Akeson",
note = "Copyright {\textcopyright} 2014 Wiley Periodicals, Inc.",
year = "2015",
month = jan,
day = "16",
doi = "10.1002/mrm.25095",
language = "English",
volume = "73",
pages = "51--58",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "JohnWiley & Sons, Inc.",
}
RIS
TY - JOUR
T1 - Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV-PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1-(13) C]pyruvate
AU - Asghar Butt, Sadia
AU - Søgaard, Lise V
AU - Ardenkjaer-Larsen, Jan H
AU - Lauritzen, Mette H
AU - Engelholm, Lars H
AU - Paulson, Olaf B.
AU - Mirza, Osman Asghar
AU - Holck, Susanne
AU - Magnusson, Peter
AU - Akeson, Per
N1 - Copyright © 2014 Wiley Periodicals, Inc.
PY - 2015/1/16
Y1 - 2015/1/16
N2 - To use dynamic magnetic resonance spectroscopy (MRS) of hyperpolarized (13) C-pyruvate to follow the progress over time in vivo of breast cancer metabolism in the MMTV-PymT model, and to follow the response to the anti-estrogen drug tamoxifen.
AB - To use dynamic magnetic resonance spectroscopy (MRS) of hyperpolarized (13) C-pyruvate to follow the progress over time in vivo of breast cancer metabolism in the MMTV-PymT model, and to follow the response to the anti-estrogen drug tamoxifen.
U2 - 10.1002/mrm.25095
DO - 10.1002/mrm.25095
M3 - Journal article
C2 - 24435823
VL - 73
SP - 51
EP - 58
JO - Magnetic Resonance in Medicine
JF - Magnetic Resonance in Medicine
SN - 0740-3194
ER -
